Accenture (ACN) said it has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd., a developer of genomic analysis and interpretation software. Terms of the investment were not disclosed.
Geneyx offers a NGS data analysis and interpretation platform, harnessing genetic data to guide digital insights for rare and germline disorders. Its AI-based analysis platform streamlines the diagnostics process.
David Yizhar, Geneyx CEO, said, "Accenture's investment and support will enable Geneyx to accelerate the adoption of our AI-based genomic interpretation technology on a global scale."
Geneyx is part of Accenture Ventures' Project Spotlight which offers extensive access to Accenture's domain expertise and its enterprise clients.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.